(19)
(11) EP 1 492 595 A1

(12)

(43) Date of publication:
05.01.2005 Bulletin 2005/01

(21) Application number: 03714045.6

(22) Date of filing: 21.03.2003
(51) International Patent Classification (IPC)7A61P 25/18, A61K 45/06, A61K 31/551, A61K 31/196
(86) International application number:
PCT/US2003/007283
(87) International publication number:
WO 2003/084610 (16.10.2003 Gazette 2003/42)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
Designated Extension States:
AL LT LV MK

(30) Priority: 03.04.2002 US 369771 P
03.04.2002 US 369797 P

(71) Applicant: ELI LILLY AND COMPANY
Indianapolis, Indiana 46285 (US)

(72) Inventors:
  • JOHNSON, Bryan, Glenn
    Indianapolis, IN 46220 (US)
  • SCHOEPP, Darryle, Darwin
    Indianapolis, IN 46202 (US)

(74) Representative: Kingsbury, Oliver William et al
Eli Lilly and Company Limited,Lilly Research Centre, Erl Wood Manor,Sunninghill Road
Windlesham, Surrey GU20 6PH
Windlesham, Surrey GU20 6PH (GB)

   


(54) THERAPY FOR PSYCHOSES COMBINING AN ATYPICAL ANTIPSYCHOTIC AND AN MGLU2/3 RECEPTOR AGONIST